Evidence map›Paper›PMID 40216970›Full record

ArticleOncogene2025

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

C -R Pradeep, A Zeisel, W J Köstler, M Lauriola, J Jacob-Hirsch, B Haibe-Kains, N Amariglio, N Ben-Chetrit, A Emde, I Solomonov and 8 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

C -R PradeepDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
A ZeiselDepartment of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.
W J KöstlerDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
M LauriolaDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
J Jacob-HirschDepartment of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
B Haibe-KainsInstitut Jules Bordet, Translational Research Unit, Brussels, Belgium.
N AmariglioDepartment of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
N Ben-ChetritDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
A EmdeDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
I SolomonovDepartment of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
G NeufeldCancer Research and Vascular Biology Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
M PiccartInstitut Jules Bordet, Translational Research Unit, Brussels, Belgium.
I SagiDepartment of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
C SotiriouInstitut Jules Bordet, Translational Research Unit, Brussels, Belgium.
G RechaviDepartment of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
E DomanyDepartment of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.
C DesmedtInstitut Jules Bordet, Translational Research Unit, Brussels, Belgium.
Y YardenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. yosef.yarden@weizmann.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40216970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.